Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-18 00:00:00 ET · period of report 2022-04-14 · accession 0000899243-22-014962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-18 | 2022-04-14 | VRTX | Lee Yuchun | Dir | S - Sale+OE | $289.06 | -2,000 | 2,675 | -43% | -$578.1K |
| D | 2022-04-18 | 2022-04-14 | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | +2,000 | 3,875 | +107% | +$163.1K |
| D | 2022-04-18 | 2022-04-14 | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -2,000 | 2,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | S | D | 400 | $291.18 | 1,875 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64). |
| 2 | Common | Common Stock | 2022-04-14 | S | D | 400 | $289.84 | 2,275 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-04-14 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-14 | S | D | 948 | $287.87 | 2,927 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-04-14 | S | D | 252 | $288.92 | 2,675 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24). |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-04-14 | M | D | 2,000 | $0.00 | 2,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F7) Fully vested. |